Subscribe to RSS

DOI: 10.1055/s-0045-1812065
Physiological Responses to Relative Hypoglycemia in Uncontrolled Type 2 Diabetes Mellitus: A Pilot Study
Authors
Funding Fundamental grant: Universiti Kebangsaan Malaysia (FF-2020-360).
Abstract
Objective
To evaluate the hormonal, cardiac, and neuronal responses during relative hypoglycemia in uncontrolled type 2 diabetes mellitus patients.
Methods
Fifteen uncontrolled type 2 diabetes mellitus patients underwent insulin infusion at 0.05 U/kg/h, titrated at 1 U/h every 10 minutes, until they developed symptoms of hypoglycemia with a glucose level >3.9 mmol/L. Blood samples for glucose, cortisol, glucagon, and epinephrine, as well as electrocardiogram and electroencephalogram readings, were taken before insulin infusion and repeated once hypoglycemic symptoms developed. Data were analyzed using paired t-tests and Wilcoxon signed-rank tests. The p-value of <0.05 was considered significant.
Results
The median glucose level during relative hypoglycemia was 6.7 (4.3–7.3) mmol/L, and 86.7% of patients experienced autonomic symptoms. The mean glucagon level was significantly higher at baseline than during relative hypoglycemia (4,842.93 vs. 4,300.13 pg/mL, p = 0.041). During relative hypoglycemia, 66.7 and 60% of patients had declined glucagon and cortisol levels, respectively. Meanwhile, 53.3% of patients experienced an increase in epinephrine levels. There was no significant change in cortisol and epinephrine levels during relative hypoglycemia compared to baseline. The electroencephalogram showed generalized background attenuation in eight patients, and none had electrocardiogram changes.
Conclusion
This study demonstrates that relative hypoglycemia, in uncontrolled type 2 diabetes mellitus, only leads to autonomic symptoms without significant counterregulatory hormonal, cardiovascular, and neurological changes. Clinically, recognizing relative hypoglycemia is crucial to avoid misinterpreting it as true hypoglycemia and to highlight its potential role in causing impaired patient awareness of subsequent true hypoglycemic episodes. The small sample size and potential confounding factors warrant cautious interpretation, and larger studies are needed to confirm these findings and to develop strategies for monitoring and managing relative hypoglycemia in clinical practice.
Keywords
relative hypoglycemia - type 2 diabetes mellitus - cortisol - glucagon - epinephrine - electroencephalogramAuthor Contribution
N.A.W.: conceptualization, formal analysis, funding acquisition, investigation, methodology, data curation, analysis, resources, supervision, and writing—review and editing. N.H.H.: data curation, formal analysis, investigation, methodology, and writing—original draft. C.S.K.: conceptualization, methodology, analysis, supervision, and writing—review and editing. S.A.S.: conceptualization, data curation, analysis, methodology, and writing—review and editing.
Compliance with Ethical Principles
The study was approved by the Research Ethics Committee Universiti Kebangsaan Malaysia (FF-2020-360). Written informed consent was obtained from all participants prior to the study.
Ethical Approval
Research Ethics Committee Universiti Kebangsaan Malaysia.
Publication History
Article published online:
31 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Hussein Z, Kamaruddin NA, Chan SP, Jain A, Uppal S, Bebakar WMW. HAT study investigators in Malaysia. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: a cohort subanalysis of the HAT study. Diabetes Res Clin Pract 2017; 133: 40-49
- 2 Cryer PE, Axelrod L, Grossman AB. et al; Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94 (03) 709-728
- 3 Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987; 79 (03) 777-781
- 4 Mitrakou A, Ryan C, Veneman T. et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991; 260 (1 Pt 1): E67-E74
- 5 Ramnanan CJ, Edgerton DS, Kraft G, Cherrington AD. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab 2011; 13 (Suppl. 01) 118-125
- 6 Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med 2010; 27 (02) 136-142
- 7 Reno CM, Litvin M, Clark AL, Fisher SJ. Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments. Endocrinol Metab Clin North Am 2013; 42 (01) 15-38
- 8 Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes 2021; 12 (12) 2036-2049
- 9 Asvold BO, Sand T, Hestad K, Bjørgaas MR. Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 2010; 33 (09) 1945-1947
- 10 Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab 2009; 297 (01) E194-E201
- 11 Larsen A, Højlund K, Poulsen MK, Madsen RE, Juhl CB. Hypoglycemia-associated electroencephalogram and electrocardiogram changes appear simultaneously. J Diabetes Sci Technol 2013; 7 (01) 93-99
- 12 Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33 (06) 1389-1394
- 13 Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 2010; 33 (07) 1591-1597
- 14 Davis IC, Ahmadizadeh I, Randell J, Younk L, Davis SN. Understanding the impact of hypoglycemia on the cardiovascular system. Expert Rev Endocrinol Metab 2017; 12 (01) 21-33
- 15 Stahn A, Pistrosch F, Ganz X. et al. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care 2014; 37 (02) 516-520
- 16 Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 2013; 62 (10) 3570-3581
- 17 Seaquist ER, Anderson J, Childs B. et al; American Diabetes Association, Endocrine Society. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab 2013; 98 (05) 1845-1859
- 18 Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007; 117 (04) 910-918
- 19 Lund A. On the role of the gut in diabetic hyperglucagonaemia. Dan Med J 2017; 64 (04) B5340
- 20 Boden G, Soriano M, Hoeldtke RD, Owen OE. Counterregulatory hormone release and glucose recovery after hypoglycemia in non-insulin-dependent diabetic patients. Diabetes 1983; 32 (11) 1055-1059
- 21 Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose Metabolism and Regulation: Beyond Insulin and Glucagon. Diabetes Spectr 2004; 17 (03) 183-190
- 22 Amiel SA, Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987; 36 (04) 518-522
- 23 Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci 2010; 1212: 12-28
- 24 Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37 (07) 901-907
- 25 Blaabjerg L, Juhl CB. Hypoglycemia-induced changes in the electroencephalogram: an overview. J Diabetes Sci Technol 2016; 10 (06) 1259-1267
- 26 Pramming S, Thorsteinsson B, Stigsby B, Binder C. Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988; 296 (6623): 665-667
- 27 Synek VM. The low-voltage electroencephalogram. Clin Electroencephalogr 1983; 14 (02) 102-105
- 28 Lindström T, Jorfeldt L, Tegler L, Arnqvist HJ. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med 1992; 9 (06) 536-541
